Prokidney reports third quarter financial results

Winston-salem, n.c., nov. 14, 2023 (globe newswire) -- prokidney corp. (nasdaq: prok) (“prokidney”), a leading late clinical-stage cellular therapeutics company focused on chronic kidney disease (ckd), today announced financial results for the third quarter ended september 30, 2023.

PROK Ratings Summary

PROK Quant Ranking